The escalating cost of drug development and unacceptably high Phase III failure rates are well-known challenges in our industry where the root causes are numerous and diverse. As we search for solutions to these challenges, the ability to design better protocols and to select the right patients, sites and countries have emerged as two key success factors.

This webinar will discuss the challenges of current practices and unique and innovative approaches that leverage data from various sources to enable real-time scenario planning during the initial phases of study design.

Participants of this webinar will learn:

• The main reasons why many Phase III trials fail and what companies are doing to mitigate the risk of failure.
• Approaches that can be taken to design better protocols and improve feasibility to avoid amendments (where possible) and mitigate failure risk as much as possible.
• Sources of investigator databases and the benefits of mastering data aggregation.
• Future possibilities for extending analytics to provide a mission control center for clinical trials.

Who Should Attend:
Professionals from pharmaceutical and biotechnology companies including:

• VP/Director Program Management
• VP/Director Clinical
• Clinical Research Scientist
• Clinical Program Manager
• Clinical Development Scientist
• Clinical Development Director
• Asset Manager
  

Registration

Registration is complimentary.
A valid business Email address is required to attend.

©2016 PAREXEL International Corp.
195 West Street Waltham, MA, 02451, USA • Tel: +1 781-487-9900

Privacy Policy | Contact Us
If you would like to change or modify your subscription preferences, click here. If you would like to unsubscribe from all PAREXEL marketing communications, click here.
©2016 PAREXEL International Corp.
This communication, including any attachments, is intended only for the person or entity to which it is addressed and may contain confidential material. Any review, retransmission, distribution or other use of this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please destroy any copies, contact the sender and delete the material from any computer. PAREXEL and Your Journey. Our Mission. are registered trademarks of PAREXEL International Corporation or its affiliates in the United States and other jurisdictions.